Ann: Invion - successful completion of P2 study of INV102, page-39

  1. 147 Posts.
    lightbulb Created with Sketch. 6
    Twigman-believe me, directors and major shareholders will not let this happen.In my opinion we have tangible first in class assets and they are assets any major pharma will want.
    Lets just wait and see what the outcome is.I believe it will make the market sit up and listen.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.5¢
Change
0.000(0.00%)
Mkt cap ! $10.59M
Open High Low Value Volume
13.0¢ 13.5¢ 12.5¢ $15.62K 118.9K

Buyers (Bids)

No. Vol. Price($)
4 213400 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 57707 2
View Market Depth
Last trade - 14.46pm 20/06/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.